I’m just wondering if anyone of you has heard about Dermadexin. It is a new medication that specifically targets SD and that is right now under regulatory review in the US and Canada for marketing approval.
It was originally developed by a small Danish company called Astion Pharmaceuticals and has then been in-licensed by Cipher Pharmaceuticals. In Europe Dermadexin is already approved as a Class III medical device but as a matter of fact hasn’t reached pharmacy shelves yet. It seems therefore likely that this medication will be first available in North America, maybe sometime next year.
Dermadexin’s mechanism of action seems to be really novel and the clinical studies they did with it delivered highly promising results. Details about the medication can be found in the related brochure:
Personally I can’t say anything good or bad about this product, I just wanted to share this information that shows that there is research going on.
All the best,